de Labry L O, Campion E W, Glynn R J, Vokonas P S
Normative Aging Study, VAOPC, Boston, MA 02108.
J Clin Epidemiol. 1990;43(2):153-7. doi: 10.1016/0895-4356(90)90178-r.
The ubiquitous white blood cell count (WBC) has rarely been analyzed as a predictor of future mortality. We examined WBC measured in prospective examinations of 2011 initially healthy men in the Normative Aging Study (mean age 47.5), followed for an average of 13.6 years with 27,402 man-years of observation. Between 1970 and 1987, 183 participants died. Mortality rates for men with baseline WBC over 9000 were 12.2/1000 man-years, 1.8-2.5 times those of men with lower WBC in each of three age groups. Proportional hazards models controlling for established risk factors including age, systolic blood pressure, cholesterol and smoking status, found WBC at the baseline exam to be an independent predictor of mortality over the following years. Even within the normal range, a difference of 1000 in the initial WBC increased the risk ratio by 1.2 (95% CI 1.1, 1.3). The relation of initial WBC to mortality was not affected by baseline age, body mass index (BMI), smoking or blood pressure. These findings are not explained by medication effects. We conclude that the WBC is an independent predictor of all-cause mortality.
普遍存在的白细胞计数(WBC)很少被作为未来死亡率的预测指标进行分析。我们在规范老化研究中对2011名最初健康的男性(平均年龄47.5岁)进行前瞻性检查时测量了白细胞计数,随访平均13.6年,观察人年数达27402人年。1970年至1987年间,有183名参与者死亡。基线白细胞计数超过9000的男性的死亡率为每1000人年12.2例,在三个年龄组中,这一死亡率是白细胞计数较低男性的1.8至2.5倍。控制年龄、收缩压、胆固醇和吸烟状况等既定风险因素的比例风险模型发现,基线检查时的白细胞计数是未来几年死亡率的独立预测指标。即使在正常范围内,初始白细胞计数相差1000也会使风险比增加1.2(95%置信区间1.1, 1.3)。初始白细胞计数与死亡率的关系不受基线年龄、体重指数(BMI)、吸烟或血压的影响。这些发现无法用药物作用来解释。我们得出结论,白细胞计数是全因死亡率的独立预测指标。